Novo A/S »

Hemab Therapeutics Holdings shares owned by Novo A/S

Quarter-by-quarter ownership of Hemab Therapeutics Holdings shares owned by Novo A/S from 13F filings

Historical chart of Novo A/S investment in Hemab Therapeutics Holdings

Tip: Access up to 7 years of quarterly data

All positions including Hemab Therapeutics Holdings held by Novo A/S consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hemab Therapeutics Holdings by Novo A/S

Quarter filed Position value Share count Share price at filing
2026-06-30 $154M 4.2M 36.73

More positions owned by Novo A/S

Edgewise Therapeutics (EWTX)
Asml Holding N V N Y Registry Shs (ASML)
Hemab Therapeutics Hldgs Com Shs
Brookfield Corp Cl A Ltd Vt Sh (BN)
Maplight Therapeutics (MPLT)
Mirum Pharmaceuticals (MIRM)
Avalyn Pharmaceuticals Com Shs
salesforce (CRM)
Arrivent Biopharma (AVBP)
Enliven Therapeutics (ELVN)
Crinetics Pharmaceuticals In (CRNX)
Pharvaris N V (PHVS)
Floor & Decor Hldgs Cl A (FND)
Vaxcyte (PCVX)
4d Molecular Therapeutics In (FDMT)

View all positions for Novo A/S

Top funds holding Hemab Therapeutics Holdings

RA Capital Management
Novo A/S
Jpmorgan Chase & Co
Vanguard Capital Management
Citadel Advisors
Braidwell
Marshall Wace
Affinity Asset Advisors
Vanguard Fiduciary Trust
Burkehill Global Management
Standard Life Aberdeen
TD Asset Management
GSA Capital Partners
Schonfeld Strategic Advisors
Vanguard Portfolio Management

View all funds holding Hemab Therapeutics Holdings